Hep C Treatment for All Genotypes Granted Priority Review

Hep C Treatment for All Genotypes Granted Priority Review “As the first fixed-dose combination of 2 pan-genotypic, direct-acting antivirals, SOF/VEL [sofosbuvir/velpatasvir] represents an important step forward in the treatment of patients with hepatitis C,” said Norbert Bischofberger, executive vice … … Continue reading